Both in Pharmaceuticals
Spero Therapeutics vs Telomir Pharmaceuticals
Over the past year SPRO returned −54.5% and TELO returned −37.9%; their daily moves had a correlation of 0.22.
SPRO −54.5% TELO −37.9%Growth of $1, one year, split-adjusted
| Metric | SPRO | TELO |
|---|---|---|
| Price | $1.07 | $0.8750 |
| Market cap | $62.3M | $64.5M |
| Today | +2.88% | −3.85% |
| 1 month | −10.1% | −27.1% |
| 6 months | −57.7% | −34.7% |
| Year to date | −54.1% | −34.2% |
| 1 year | −55.0% | −41.7% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 8.4× | — |
| Price / sales | 1.3× | — |
| Net cash | $50.7M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 59.0% | 46.6% |
| Short % of float | 2.0% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).